The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy

Facioscapulohumeral muscular dystrophy (FSHD) is a prevalent, incurable skeletal myopathy. Clinical trials for FSHD are hindered by heterogeneous biomarkers poorly associated with clinical severity, requiring invasive muscle biopsy. Macroscopically, FSHD presents with slow fatty replacement of muscl...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerji, Christopher R S, Greco, Anna, Joosten, Leo A B, van Engelen, Baziel G M, Zammit, Peter S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507741/
https://www.ncbi.nlm.nih.gov/pubmed/37731904
http://dx.doi.org/10.1093/braincomms/fcad221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507741/
https://www.ncbi.nlm.nih.gov/pubmed/37731904
http://dx.doi.org/10.1093/braincomms/fcad221

Ejemplares similares